Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Cyclopenthiazide adverse reaction |
Causative agent (attribute) |
True |
Cyclopenthiazide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Allergy to cyclopenthiazide (finding) |
Causative agent (attribute) |
False |
Cyclopenthiazide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing cyclopenthiazide (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Cyclopenthiazide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely cyclopenthiazide 500 microgram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cyclopenthiazide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Amiloride hydrochloride 2.5 mg and cyclopenthiazide 250 microgram oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cyclopenthiazide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Amiloride hydrochloride+cyclopenthiazide |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cyclopenthiazide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Co-prenozide 160mg/0.25mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cyclopenthiazide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Cyclopenthiazide- and oxprenolol-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Cyclopenthiazide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing amiloride and cyclopenthiazide (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Cyclopenthiazide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Allergy to cyclopenthiazide (finding) |
Causative agent (attribute) |
True |
Cyclopenthiazide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Amiloride hydrochloride 2.5 mg and cyclopenthiazide 250 microgram oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cyclopenthiazide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Amiloride hydrochloride 2.5 mg and cyclopenthiazide 250 microgram oral tablet |
Has basis of strength substance (attribute) |
False |
Cyclopenthiazide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely cyclopenthiazide 500 microgram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cyclopenthiazide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely cyclopenthiazide 500 microgram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Cyclopenthiazide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely cyclopenthiazide 250 microgram and oxprenolol hydrochloride 160 milligram/1 each prolonged-release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
False |
Cyclopenthiazide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely cyclopenthiazide 250 microgram and oxprenolol hydrochloride 160 milligram/1 each prolonged-release oral tablet (clinical drug) |
Has precise active ingredient |
False |
Cyclopenthiazide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Cyclopenthiazide- and oxprenolol-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Cyclopenthiazide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Amiloride hydrochloride 2.5 mg and cyclopenthiazide 250 microgram oral tablet |
Has precise active ingredient |
False |
Cyclopenthiazide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Amiloride- and cyclopenthiazide-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Cyclopenthiazide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely cyclopenthiazide 500 microgram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Cyclopenthiazide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Cyclopenthiazide-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Cyclopenthiazide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only amiloride and cyclopenthiazide (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Cyclopenthiazide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing only cyclopenthiazide (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Cyclopenthiazide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only cyclopenthiazide and oxprenolol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Cyclopenthiazide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing only amiloride and cyclopenthiazide in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Cyclopenthiazide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing only cyclopenthiazide and oxprenolol in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Cyclopenthiazide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing only cyclopenthiazide in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Cyclopenthiazide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Amiloride hydrochloride 2.5 mg and cyclopenthiazide 250 microgram oral tablet |
Has basis of strength substance (attribute) |
True |
Cyclopenthiazide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Amiloride hydrochloride 2.5 mg and cyclopenthiazide 250 microgram oral tablet |
Has precise active ingredient |
True |
Cyclopenthiazide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely cyclopenthiazide 250 microgram and oxprenolol hydrochloride 160 milligram/1 each prolonged-release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Cyclopenthiazide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely cyclopenthiazide 250 microgram and oxprenolol hydrochloride 160 milligram/1 each prolonged-release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Cyclopenthiazide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |